HK1149545A1 - Compositions and methods for treating ophthalmic diseases - Google Patents

Compositions and methods for treating ophthalmic diseases

Info

Publication number
HK1149545A1
HK1149545A1 HK11103917.1A HK11103917A HK1149545A1 HK 1149545 A1 HK1149545 A1 HK 1149545A1 HK 11103917 A HK11103917 A HK 11103917A HK 1149545 A1 HK1149545 A1 HK 1149545A1
Authority
HK
Hong Kong
Prior art keywords
compositions
methods
ophthalmic diseases
treating ophthalmic
treating
Prior art date
Application number
HK11103917.1A
Other languages
English (en)
Chinese (zh)
Inventor
‧科恩
‧韓
‧約維尼
Original Assignee
拉特格斯，新澤西州立大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 拉特格斯，新澤西州立大學 filed Critical 拉特格斯，新澤西州立大學
Publication of HK1149545A1 publication Critical patent/HK1149545A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK11103917.1A 2008-02-21 2011-04-19 Compositions and methods for treating ophthalmic diseases HK1149545A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3045708P 2008-02-21 2008-02-21
US13937808P 2008-12-19 2008-12-19
PCT/US2009/034746 WO2009105692A1 (en) 2008-02-21 2009-02-20 Compositions and methods for treating ophthalmic diseases

Publications (1)

Publication Number Publication Date
HK1149545A1 true HK1149545A1 (en) 2011-10-07

Family

ID=42729350

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11103917.1A HK1149545A1 (en) 2008-02-21 2011-04-19 Compositions and methods for treating ophthalmic diseases

Country Status (9)

Country Link
US (2) US8173163B2 (de)
EP (1) EP2254857A4 (de)
JP (1) JP5702152B2 (de)
CN (1) CN101977886B (de)
AU (1) AU2009217337B2 (de)
CA (1) CA2716185C (de)
HK (1) HK1149545A1 (de)
MX (1) MX350711B (de)
WO (1) WO2009105692A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8361492B2 (en) * 2008-04-29 2013-01-29 Ocugenics, LLC Drug delivery system and methods of use
US8083347B2 (en) * 2008-04-29 2011-12-27 Ocugenics, LLC Drug delivery system and methods of use
US8895080B2 (en) * 2008-06-20 2014-11-25 Ocusoft, Inc. Compositions and kits for ocular treatment
US9956168B2 (en) 2013-06-20 2018-05-01 Mercy Medical Research Institute Extended release drug-delivery contact lenses and methods of making
EP3079668A1 (de) 2013-12-09 2016-10-19 Durect Corporation Pharmazeutisch aktive wirkstoffkomplexe, polymerkomplexe und zusammensetzungen und verfahren damit
CA3087410A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
US11690807B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
CN108727597A (zh) * 2018-06-08 2018-11-02 中国科学技术大学 聚磷酸酯-聚己内酯纳米药物载体及其应用
CN109593188B (zh) * 2018-11-02 2021-09-28 华东理工大学 一种基于强碱性离子液体高效催化制备聚碳酸酯的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587507A (en) 1995-03-31 1996-12-24 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5837448A (en) 1992-05-15 1998-11-17 The Salk Institute For Biological Studies Protein-tyrosine kinase genes
US5877224A (en) 1995-07-28 1999-03-02 Rutgers, The State University Of New Jersey Polymeric drug formulations
US5658995A (en) 1995-11-27 1997-08-19 Rutgers, The State University Copolymers of tyrosine-based polycarbonate and poly(alkylene oxide)
US6120491A (en) * 1997-11-07 2000-09-19 The State University Rutgers Biodegradable, anionic polymers derived from the amino acid L-tyrosine
US5912225A (en) 1997-04-14 1999-06-15 Johns Hopkins Univ. School Of Medicine Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
KR100360827B1 (ko) * 1999-08-14 2002-11-18 주식회사 삼양사 난용성 약물을 가용화하기 위한 고분자 조성물 및 그의 제조방법
EP2316490A3 (de) * 2000-10-31 2012-02-01 PR Pharmaceuticals, Inc. Verfahren und Formulierungen zur verbesserten Abgabe von bioaktiven Molekülen
US8591951B2 (en) * 2002-05-15 2013-11-26 Joachim B. Kohn Tri-block copolymers for nanosphere-based drug delivery
AU2004275878B2 (en) * 2003-09-25 2011-04-14 Rutgers, The State University Inherently radiopaque polymeric products for embolotherapy
EP2286791B1 (de) * 2003-12-30 2014-03-26 Durect Corporation Polymereimplantate, welche vorzugsweise ein Gemisch von PEG und PLG enthalten, für kontrollierte Freisetzung von Wirkstoffen
WO2006023130A2 (en) * 2004-08-12 2006-03-02 Surmodics, Inc. Biodegradable controlled release bioactive agent delivery device
US20060034769A1 (en) 2004-08-13 2006-02-16 Rutgers, The State University Radiopaque polymeric stents
CN101065153B (zh) * 2004-08-13 2013-02-20 罗格斯州立大学 不透射线性聚合物支架
US7709049B2 (en) * 2004-09-10 2010-05-04 Surmodics, Inc. Methods, devices, and coatings for controlled active agent release
JP5668476B2 (ja) * 2007-10-08 2015-02-12 オーリニア・ファーマシューティカルズ・インコーポレイテッドＡｕｒｉｎｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． カルシニューリン阻害剤またはｍＴＯＲ阻害剤を含む眼科用組成物

Also Published As

Publication number Publication date
CA2716185C (en) 2017-03-21
AU2009217337B2 (en) 2013-10-10
CN101977886B (zh) 2014-10-15
MX350711B (es) 2017-09-12
CN101977886A (zh) 2011-02-16
CA2716185A1 (en) 2009-08-27
EP2254857A4 (de) 2014-06-25
US20090238858A1 (en) 2009-09-24
AU2009217337A1 (en) 2009-08-27
MX2010009115A (es) 2010-11-25
US20120207796A1 (en) 2012-08-16
JP5702152B2 (ja) 2015-04-15
JP2011516409A (ja) 2011-05-26
EP2254857A1 (de) 2010-12-01
WO2009105692A1 (en) 2009-08-27
US8367110B2 (en) 2013-02-05
US8173163B2 (en) 2012-05-08

Similar Documents

Publication Publication Date Title
HK1247821A1 (zh) 用於預防或治療眼科病症的方法和組合物
EP2176283A4 (de) Verfahren und zusammensetzungen zur behandlung von hirnerkrankungen
ZA200908711B (en) Methods and compositions for treating allergic diseases
HK1201046A1 (en) Methods of treating ophthalmic diseases
HK1158172A1 (en) Compounds for treating ophthalmic diseases and disorders
EP2083862A4 (de) Zusammensetzungen und verfahren zur behandlung von augenerkrankungen und -leiden
EP2432476A4 (de) Verfahren zur behandlung oder prävention von augenerkrankungen
SI2374472T1 (sl) Sestavki in postopki za zdravljenje oftalmoloških motenj
EP2655334A4 (de) Zusammensetzungen und verfahren zur behandlung von erkrankungen
IL202015A0 (en) Methods and compositions for treating skin conditions
IL192878A0 (en) Compositions and methods for treating collagen-mediated diseases
PL2349231T3 (pl) Kompozycje i metody leczenia chorób kopyta
EP2497482A4 (de) Zusammensetzung zur prophylaxe und behandlung influenzavirus-induzierter erkrankungen
HK1149545A1 (en) Compositions and methods for treating ophthalmic diseases
ZA201008201B (en) Novel compositions and methods for treating hyperproliferative diseases
HK1245679A1 (zh) 用於治療皮膚疾病和病症的方法和組合物
EP2341936A4 (de) VERFAHREN ZUR BEHANDLUNG ODER PRÄVENTION VON IL-1ß-BEDINGTEN ERKRANKUNGEN
GB0915259D0 (en) Sulphur-linked compounds for treating ophthalmic diseases and disorders
EP2274411A4 (de) Xanthohumol-zusammensetzungen und verfahren zur behandlung von hautkrankheiten oder -störungen
EP2558104A4 (de) Verfahren und ophthalmische zusammensetzung zur behandlung von netzhauterkrankungen
IL210840A0 (en) Methods and compositions for treating and preventing autoimmune diseases
IL209947A0 (en) Compositions and methods for treating corneal inflammation
EP2237777A4 (de) Zusammensetzungen und verfahren zur behandlung neurodegenerativer erkrankungen
EP2427052A4 (de) Verfahren und zusammensetzungen zur behandlung von augenleiden
EP2462131A4 (de) Zusammensetzungen und verfahren zur behandlung beta-amyloid-vermittelter erkrankungen

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220224